DrugDashboards

Market view

neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride · Cream

9 marketed package NDCs · 7 active manufacturers

Most dispensed: 3.5 mg/g; 10000 [USP'U]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g · Cream · #1 tube/carton / 14.2 g in 1 tube · 3.5 mg/g; 10000 [iU]/g; PRAMOXINE HYDROCHLORIDE 10 mg/g · Cream · #1 tube/carton / 14.2 g in 1 tube

The short version

7 companies supply this market — a reasonable cushion if one runs into trouble. The price has held steady around $0.1887 per gram over the past year.

Price range and competition

RSS: changes for this drug

Every company selling this drug reports its own price. The line follows the middle of the pack; the shaded band holds the middle half of companies — the wider it is, the more they disagree.

$0$0.1$0.2Sep 2024Aug 202607companies actively selling

Latest · Aug 2026 — typical price $0.1887 · middle half $0.1887$0.1887 · full range $0.1887$0.1887 · 1 products · 7 companies

middle half of companies’ pricestypical (median) pricecompanies actively selling (bottom lane)Priced per gramSource: CMS NADAC
ⓘ How this was built
Data sources
  • CMS NADAC weekly survey + monthly archives back to 2013 (data.medicaid.gov)
  • CMS Federal Upper Limit files (weighted AMP)
  • FDA NDC Directory (openFDA) — maker roster
Method

Each month's band spans the NADAC unit prices of every NDC of this drug (min, quartiles, median, max), split into brand and generic cohorts by FDA marketing category. Maker counts come from distinct labelers with the NDC actively listed.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

What changed in the last 90 days

Every detected change for neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

  • Mfr exited
    Target Corporation · neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride
  • Mfr entered
    Target Corporation · neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride
  • Mfr exited
    Target Corporation · neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride
  • Mfr entered
    Target Corporation · neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride

Same drug class

Other molecules FDA puts in Aminoglycoside Antibacterial, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride in shortage right now?
No. FDA does not currently list Neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
Who makes Neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride?
7 companies have marketed Neomycin sulfate, polymyxin b sulfate, and pramoxine hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.